Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors

Priscilla K. Stumpf, Ellen D. Yorke, Issam El Naqa, Kyle C. Cuneo, Jimm Grimm, Karyn A. Goodman

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Purpose: Stereotactic body radiation therapy (SBRT) in the management of adrenal metastases is emerging as a well-tolerated, effective method of treatment for patients with limited metastatic disease. SBRT planning and treatment utilization are widely variable, and publications report heterogeneous radiation dose fractionation schemes and treatment outcomes. The objective of this analysis was to review the current literature on SBRT for adrenal metastases and to develop treatment guidelines and a model for tumor control probability of SBRT for adrenal metastases based on these publications. Methods and Materials: A literature search of all studies on SBRT for adrenal metastases published from 2008 to 2017 was performed, and outcomes in these studies were reviewed. Local control (LC) rates were fit to a statistically significant Poisson model using maximum likelihood estimation techniques. Results: One-year LC greater than 95% was achieved at an approximated biological equivalent dose with α/β = 10 Gy of 116.4 Gy. Conclusions: While respecting normal tissue tolerances, tumor doses greater than or equal to a biological equivalent dose with α/β = 10 Gy of 116.4 Gy are recommended to achieve high LC. Further studies following unified reporting standards are needed for more robust prediction.

Original languageEnglish
Pages (from-to)217-226
Number of pages10
JournalInternational Journal of Radiation Oncology Biology Physics
Volume110
Issue number1
DOIs
StatePublished - 1 May 2021

Fingerprint

Dive into the research topics of 'Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors'. Together they form a unique fingerprint.

Cite this